دورية أكاديمية
Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway
| العنوان: | Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway |
|---|---|
| المؤلفون: | Marchetti Sabina, Guzzetta Giorgio, Flem Elmira, Mirinaviciute Grazina, Scalia Tomba Gianpaolo, Manfredi Pietro Angelo |
| المساهمون: | Marchetti, Sabina, Guzzetta, Giorgio, Flem, Elmira, Mirinaviciute, Grazina, Scalia Tomba, Gianpaolo, Manfredi, PIETRO ANGELO MANFREDO FRANCESCO |
| سنة النشر: | 2018 |
| المجموعة: | ARPI - Archivio della Ricerca dell'Università di Pisa |
| مصطلحات موضوعية: | Exogenous boosting hypothesi, Herpes zoster immunization, Mathematical model, Universal vs targeted varicella vaccination, Varicella-zoster virus (VZV), Adolescent, Chickenpox, Chickenpox Vaccine, Herpes Zoster, Herpes Zoster Vaccine |
| الوصف: | Background: Adoption of varicella immunization in Europe is limited due to a predicted increase in the incidence of herpes zoster (HZ) resulting from a removal of exogenous boosting by varicella vaccination. Most available assessments of immunization strategies only considered universal varicella vaccination (alone or in combination with HZ by the live vaccine). The development of a new subunit recombinant zoster vaccine may provide new perspectives of HZ control. Methods: We used a mathematical model for VZV in Norway based on the progressive immunity formulation of exogenous boosting. We evaluated a complete range of alternative immunization options against varicella and HZ including both universal and targeted varicella vaccination, either alone or with zoster immunization, and zoster immunization alone. We considered all values of the boosting intensity consistent with the Norwegian HZ incidence and compared the performance of the currently available live vaccine vs. a new recombinant vaccine. Results: Universal varicella vaccination alone resulted in a marked increase in the incidence of HZ under all scenarios considered. Even under the most favorable hypotheses on the magnitude of the boosting intensity, this increase could be mitigated only by a parallel HZ immunization with a recombinant vaccine, assuming a long duration of protection. Targeted varicella immunization of adolescents resulted in a modest increase in the HZ incidence which could be counterbalanced by both the live and, especially, the recombinant vaccine. Conclusions: Given current knowledge on HZ pathogenesis and exogenous boosting, targeted varicella vaccination of adolescents was the only strategy that was not predicted to impact the epidemiology of HZ, and therefore it may represent a suitable alternative to universal vaccination. These results are aimed to support vaccine policy decisions in Norway and other countries with a similar VZV epidemiology. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | STAMPA |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/29366704; info:eu-repo/semantics/altIdentifier/wos/WOS:000425205100013; volume:36; issue:8; firstpage:1116; lastpage:1125; numberofpages:10; journal:VACCINE; http://hdl.handle.net/11568/956059Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85040641986; www.elsevier.com/locate/vaccine |
| DOI: | 10.1016/j.vaccine.2018.01.038 |
| الإتاحة: | https://doi.org/10.1016/j.vaccine.2018.01.038Test http://hdl.handle.net/11568/956059Test |
| رقم الانضمام: | edsbas.E9293B90 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.vaccine.2018.01.038 |
|---|